Clinical Trials Browser

Leukemia, Myelomonocytic, Chronic

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Prostatic Neoplasms

Allogeneic Stem Cell Transplantation

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Oropharyngeal Neoplasms

Cytopenia, Anemia, Thrombocytopenia

Pancreatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Borderline Resectable Pancreatic Adenocarcinoma

Triple Negative Breast Neoplasms

Multiple Myeloma

Hematologic Neoplasms

Lung Neoplasms

Stomatitis, Ulcer

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Adenoviridae Infections, Urinary Bladder Neoplasms

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

Lung Neoplasms

Mesothelioma, Malignant, Mesothelioma

Early Stage Triple Negative ER Low Breast Cancer

Rectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Kidney Neoplasms

Colorectal Neoplasms

Brain Neoplasms, Glioblastoma, Glioma, Herpes Simplex, Neoplasms, Virus Diseases

Colorectal Neoplasms

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Follicular

Sarcoma, Kaposi

Adenocarcinoma

Carcinoma, Non-Small-Cell Lung, Melanoma

Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Liposarcoma, Neoplasms, Sarcoma

Head and Neck Neoplasms

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Colorectal Neoplasms

HER2-positive Breast Cancer

Clinical Trials

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

Resimmune®

PEM-PRO

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

T-ALL-2024

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Immunotherapy Before and After Surgery

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

ADJUNCT

BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Perioperative Immunotherapy for NSCLC (ECTOP-1030)

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

HARMONY

ECLAT

MONAMI

Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

exBOND

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

INDIGO

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

OZM-034

A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

MK-5890-003

Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

INAVO-CRC

Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Mandolin

A Study of ONC201 for Refractory Meningioma

PULSAR

BEMAFLOT

EPIC

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

CaptAin

IMpALA

NeoSarc

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

PRISM

A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

COMUNITY

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer